UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Editor's Note: Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7), p.1161-1161

2023

Link zum Volltext

Verfügbarkeit prüfen

Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2132-2144

2008

Link zum Volltext

Verfügbarkeit prüfen

TESTING FOR TREATMENT DIFFERENCES WITH DROPOUTS PRESENT IN CLINICAL TRIALS - A COMPOSITE APPROACH

Statistics in medicine, 1997-06, Vol.16 (11), p.1225-1239

1997

Link zum Volltext

Verfügbarkeit prüfen

A Critical Role for p27kip1 Gene Dosage in a Mouse Model of Prostate Carcinogenesis

Proceedings of the National Academy of Sciences - PNAS, 2004-12, Vol.101 (49), p.17204-17209

2004

Link zum Volltext

Verfügbarkeit prüfen

Sample size re-estimation - journey for a decade

Statistics in medicine, 2001-02, Vol.20 (4), p.515-518

Shih, Weichung Joseph

2001

Link zum Volltext

Verfügbarkeit prüfen

Evaluating Correlation with Proper Bounds

Biometrics, 1992-12, Vol.48 (4), p.1207-1213

1992

Link zum Volltext

Verfügbarkeit prüfen

Analysis of pilot and early phase studies with small sample sizes

Statistics in medicine, 2004-06, Vol.23 (12), p.1827-1842

2004

Link zum Volltext

Verfügbarkeit prüfen

Sample Size and Power Calculations for Periodontal and Other Studies with Clustered Samples Using the Method of Generalized Estimating Equations

Biometrical journal, 1997, Vol.39 (8), p.899-908

Shih, Weichung Joseph

1997

Link zum Volltext

Verfügbarkeit prüfen

A critical role for p27 super(kip1) gene dosage in a mouse model of prostate carcinogenesis

Proceedings of the National Academy of Sciences - PNAS, 2004-12, Vol.101 (49), p.17204-17209

2004

Link zum Volltext

Verfügbarkeit prüfen

A critical role for p27 kip1 gene dosage in a mouse model of prostate carcinogenesis

Proceedings of the National Academy of Sciences - PNAS, 2004-12, Vol.101 (49), p.17204-17209

2004

Link zum Volltext

Verfügbarkeit prüfen

Stratified testing for treatment effects with missing data

Biometrics, 1998-06, Vol.54 (1), p.782

1998

Link zum Volltext

Verfügbarkeit prüfen

Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance

Communications in statistics. Theory and methods, 1992-01, Vol.21 (10), p.2833-2853

1992

Link zum Volltext

Verfügbarkeit prüfen

Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes

Statistics in medicine, 1997-09, Vol.16 (17), p.1913-1923

1997

Link zum Volltext

Verfügbarkeit prüfen

Type I error in sample size re-estimations based on observed treatment différence. Commentary. Rejoinder

Statistics in medicine, 2001, Vol.20 (4), p.497-520

2001

Link zum Volltext

Verfügbarkeit prüfen

Stratified Testing for Treatment Effects with Missing Data

Biometrics, 1998-06, Vol.54 (2), p.782-787

1998

Link zum Volltext

Verfügbarkeit prüfen

ON THE COMPOSITE APPROACH TO DROPOUTS IN CLINICAL TRIALS

Statistica Sinica, 2001-01, Vol.11 (1), p.53-61

2001

Link zum Volltext

Verfügbarkeit prüfen

Re-evaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of change

Statistics in medicine, 1995-10, Vol.14 (20), p.2239-2248

1995

Link zum Volltext

Verfügbarkeit prüfen

Sample Size Reestimation for Triple Blind Clinical Trials

Therapeutic innovation & regulatory science, 1993-07, Vol.27 (3), p.761-764

Shih, Weichung Joseph

1993

Link zum Volltext

Verfügbarkeit prüfen

A geometric approach to the analysis of physiological flow data

Statistics in medicine, 1994-02, Vol.13 (3), p.261-273

Shih, Weichung Joseph

1994

Link zum Volltext

Verfügbarkeit prüfen

On Informative and Random Dropouts in Longitudinal Studies

Biometrics, 1992-09, Vol.48 (3), p.970-972

Shih, Weichung Joseph

1992

Link zum Volltext

Verfügbarkeit prüfen

Interim analyses for sample size reestimation without unblinding treatment group identification in double-blind clinical trials

Controlled clinical trials, 1990-08, Vol.11 (4), p.264-264

1990

Link zum Volltext

Verfügbarkeit prüfen

Monitoring of clinical trials and interim analyses from a drug Sponsor's point of view

Statistics in medicine, 1993-03, Vol.12 (5-6), p.481-492

1993

Link zum Volltext

Verfügbarkeit prüfen

Influence of incomplete observations in multiple linear regression

Statistics & probability letters, 1989-06, Vol.8 (2), p.171-174

Shih, Weichung Joseph

1989

Link zum Volltext

Verfügbarkeit prüfen

A note on the analysis of titration studies

Statistics in medicine, 1991-03, Vol.10 (3), p.323-328

1991

Link zum Volltext

Verfügbarkeit prüfen

The analysis of titration studies in phase III clinical trials

Statistics in medicine, 1989-05, Vol.8 (5), p.583-591

1989

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Englisch
(70)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(26)
Humans
(23)
Mathematics
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Physical Sciences
(13)
Statistics & Probability
(13)
Mathematical & Computational Biology
(11)
Oncology
(11)
Male
(8)
Medicine, Research & Experimental
(8)
Public, Environmental & Occupational Health
(8)
Research & Experimental Medicine
(8)
Medical Informatics
(7)
Clinical Trials
(6)
Female
(5)
Medical Statistics
(5)
Sample Size
(5)
Tumors
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Editor's Note: Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer

Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer

TESTING FOR TREATMENT DIFFERENCES WITH DROPOUTS PRESENT IN CLINICAL TRIALS - A COMPOSITE APPROACH

A Critical Role for p27kip1 Gene Dosage in a Mouse Model of Prostate Carcinogenesis

Sample size re-estimation - journey for a decade

Evaluating Correlation with Proper Bounds

Analysis of pilot and early phase studies with small sample sizes

Sample Size and Power Calculations for Periodontal and Other Studies with Clustered Samples Using the Method of Generalized Estimating Equations

A critical role for p27 super(kip1) gene dosage in a mouse model of prostate carcinogenesis

A critical role for p27 kip1 gene dosage in a mouse model of prostate carcinogenesis

Stratified testing for treatment effects with missing data

Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance

Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes

Type I error in sample size re-estimations based on observed treatment différence. Commentary. Rejoinder

Stratified Testing for Treatment Effects with Missing Data

ON THE COMPOSITE APPROACH TO DROPOUTS IN CLINICAL TRIALS

Re-evaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of change

Sample Size Reestimation for Triple Blind Clinical Trials

A geometric approach to the analysis of physiological flow data

On Informative and Random Dropouts in Longitudinal Studies

Interim analyses for sample size reestimation without unblinding treatment group identification in double-blind clinical trials

Monitoring of clinical trials and interim analyses from a drug Sponsor's point of view

Influence of incomplete observations in multiple linear regression

A note on the analysis of titration studies

The analysis of titration studies in phase III clinical trials

Suchergebnisse filtern